Starboard joins opposition to Bristol-Myers’ $74 billion Celgene deal
FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near Agen, France March 29, 2018. REUTERS/Regis Duvignau/File Photo February 28, 2019 By Svea Herbst-Bayliss and Michael Erman (Reuters) – Activist hedge fund Starboard Value LP followed Bristol-Myers Squibb Co’s […]
